Elekta AB (publ)
Elekta AB (publ) operates in the Health Care Equipment & Supplies industry, providing radiation therapy systems and software for cancer treatment.
Business. Elekta AB (publ) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Sweden and is primarily listed on the NASDAQ under the ticker symbol EKTAY.O. Specific details regarding the company's operating segments and geographic revenue mix are not provided in the available data. Consequently, the business is described at the industry level as a provider of health care equipment and supplies.
Analyst recommendations
16 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Elekta AB (publ) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Sweden and is primarily listed on the NASDAQ under the ticker symbol EKTAY.O. Specific details regarding the company's operating segments and geographic revenue mix are not provided in the available data. Consequently, the business is described at the industry level as a provider of health care equipment and supplies.
Elekta’s capital structure is characterized by significant leverage and tight liquidity. The company reports total equity of SEK 7.1 billion against total liabilities of SEK 19.9 billion, resulting in a debt-to-equity ratio of 1.03. Long-term debt stands at SEK 7.3 billion, while cash and equivalents are limited to SEK 2.3 billion, leading to a negative net cash position. The current ratio of 0.87 indicates that current liabilities exceed current assets, signaling medium liquidity risk. The market capitalization is SEK 1.78 billion, implying a substantial discount to book value with a price-to-book ratio of 0.25.
Profitability metrics are currently negative, reflecting operational challenges. Net income is -SEK 519 million, yielding a return on equity (ROE) of -4.03% and a return on assets (ROA) of -1.06%. While gross profit is SEK 6.25 billion on revenue of SEK 16.72 billion, operating income is compressed to SEK 239 million, indicating high operating expenses relative to sales. The EV/EBITDA multiple is 12.61, and EV/Revenue is 0.38, suggesting the market prices the company conservatively given its current earnings trajectory.
Revenue concentration and geographic exposure details are not provided in the available data. The company’s total revenue is SEK 16.72 billion, but specific segment breakdowns or regional contributions are absent from the current snapshot. Consequently, analysis of revenue concentration risk or geographic diversification cannot be performed based on the present information.
Growth trajectory analysis is limited due to the absence of historical period data. The current financial snapshot provides a single-period view of revenue and net income. Without 5-year annual or 8-quarter quarterly data, it is not possible to assess year-over-year growth rates, revenue trends, or the consistency of earnings performance over time.
Risk assessment highlights medium liquidity risk and low dilution risk. Key flags indicate that net cash is negative after subtracting total debt, which constrains financial flexibility. The dilution risk is assessed as low, with basic and diluted shares outstanding being identical at 367.1 million, suggesting no immediate significant option or warrant dilution. The primary financial risk stems from the leverage profile and the ability to service debt given the current negative net income.
Recent events and market sentiment are reflected in analyst estimates. The mean price target is SEK 57.50, with a median of SEK 55.00, significantly higher than the current market price of SEK 4.86. The mean recommendation is 3.06, indicating a neutral to slightly bearish consensus, with 2 strong buys, 4 buys, and 3 holds. No specific filing, news, or transcript observations are provided in the current data set to detail recent corporate actions or strategic announcements.
- The company trades at a deep discount to book value (P/B 0.25) with a market cap of SEK 1.78 billion.
- Liquidity is constrained with a current ratio of 0.87 and negative net cash position.
- Profitability is negative with ROE of -4.03% and net income of -SEK 519 million.
- Analyst consensus suggests upside potential with a mean price target of SEK 57.50.
- Dilution risk is low with no difference between basic and diluted share counts.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue kr 4.76B; Operating income -kr 461.0M.
- ▍Revenue kr 4.76B
- ▍Operating income -kr 461.0M
- ▍Net margin -18.2%
Revenue kr 4.24B, −9,7% YoY; Operating income −83,4% YoY.
- ▍Revenue kr 4.24B, −9,7% YoY
- ▍Operating income −83,4% YoY
- ▍Net income −97,4% YoY
- ▍Free cash flow −84,1% YoY
- ▍Net margin 0.2%
Revenue kr 4.07B, −6,2% YoY; Operating income +0,5% YoY.
- ▍Revenue kr 4.07B, −6,2% YoY
- ▍Operating income +0,5% YoY
- ▍Net income +9,0% YoY
- ▍Free cash flow +463,8% YoY
- ▍Net margin 5.7%
Revenue kr 4.70B; Operating income kr 525.0M.
- ▍Revenue kr 4.70B
- ▍Operating income kr 525.0M
- ▍Net margin 7.3%
Revenue kr 4.34B; Operating income kr 388.0M.
- ▍Revenue kr 4.34B
- ▍Operating income kr 388.0M
- ▍Net margin 4.9%
Revenue kr 3.83B; Operating income kr 174.0M.
- ▍Revenue kr 3.83B
- ▍Operating income kr 174.0M
- ▍Net margin 1.9%
Revenue kr 16.72B, −7,2% YoY; Operating income −74,0% YoY.
- ▍Revenue kr 16.72B, −7,2% YoY
- ▍Operating income −74,0% YoY
- ▍Net income −319,9% YoY
- ▍Free cash flow −32,6% YoY
- ▍Net margin -3.1%
Revenue kr 18.02B, −0,6% YoY; Operating income −56,4% YoY.
- ▍Revenue kr 18.02B, −0,6% YoY
- ▍Operating income −56,4% YoY
- ▍Net income −81,9% YoY
- ▍Free cash flow −676,2% YoY
- ▍Net margin 1.3%
Revenue kr 18.12B, +7,4% YoY; Operating income +46,1% YoY.
- ▍Revenue kr 18.12B, +7,4% YoY
- ▍Operating income +46,1% YoY
- ▍Net income +38,2% YoY
- ▍Free cash flow +74,3% YoY
- ▍Net margin 7.2%
Revenue kr 16.87B, +15,9% YoY; Operating income −13,9% YoY.
- ▍Revenue kr 16.87B, +15,9% YoY
- ▍Operating income −13,9% YoY
- ▍Net income −18,2% YoY
- ▍Free cash flow −761,8% YoY
- ▍Net margin 5.6%
Revenue kr 14.55B; Operating income kr 1.64B.
- ▍Revenue kr 14.55B
- ▍Operating income kr 1.64B
- ▍Net margin 7.9%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Elekta AB (publ) Market data — financials · 2026-07-24
- Elekta AB (publ) Market data — analyst estimates · 2026-07-24
- Elekta AB (publ) Market data — ESG · 2026-07-24
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M